Skip to main content
SpringerLink
Log in

β-Receptorenblocker

  • Chapter
Herzkrankheiten

  • 32 Accesses

Zusammenfassung

β-Receptorenblocker haben sich in den letzten 20 Jahren aus Laboratoriumswerkzeugen eines kleinen Kreises eingeweihter Physiologen und Pharmakologen zu einem festen Bestandteil der Arzneimitteltherapie entwickelt. Angina pectoris, Hochdruck, Arrhythmien und funktionelle Herz-Kreislauf-Störungen sind heute nicht mehr umstrittene Indikationen für diese Substanzgruppe, die uns als Instrument der Forschung Einblick in eine Vielzahl physiologischer und pathophysiologischer Vorgänge vermittelt hat.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahlquist, R. P.: A study of the adrenotropic receptors. Amer. J. Physiol. 153, 586 (1948).

    PubMed  CAS  Google Scholar 

  • Aström, H.: Clinical pharmacodynamics of beta-adrenergic blockers. In: Beta-adrenerge Blocker und Hochdruck (D. Ganten, R. Dietz, B. Loth, F. Gross, Hrsg.), S. 46. Stuttgart: Thieme 1976.

    Google Scholar 

  • Barret, A. M.: The pharmacology of practolol. Postgrad. med. J. 47 (Suppl.), 7 (1971).

    Google Scholar 

  • Bennet, A., Whitney, B.: A pharmacological investigation of human isolated stomach. Brit. J. Pharmacol. 27, 286 (1966).

    Google Scholar 

  • Black, J. W., Stephenson, J. S.: Pharmacology of a new adrenergic /3-receptor blocking compound (nethalide). Lancet 1962 II, 311.

    Article  Google Scholar 

  • Black, J. W., Duncan, W. A. M., Shanks, R. G.: Comparison of some properties of pronethalol and propranolol. Brit. J. Pharmacol. 25, 577 (1965).

    PubMed  CAS  Google Scholar 

  • Bond, P. A., Howe, R.: The metabolism of pronethalol. Biochem. Pharmacol. 16, 1261 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Botelho, S. Y., Goldstein, A. M., Martinez, E. V.: Norepinephrine responsive beta-adrenergic receptors in rabbit lacrimal gland. Amer. J. Physiol. 224, 1119 (1973).

    PubMed  CAS  Google Scholar 

  • Brunner, H., Imhof, P.: Bedeutung der kardioselektiven Wirkung und der „Intrinsic Activity“ für die klinische Anwendung der Beta-adrenergen Blocker. In: Beta-adrenerge Blocker und Hochdruck (D. Ganten, R. Dietz, B. Loth, F. Gross, Hrsg.), S. 27. Stuttgart: Thieme 1976.

    Google Scholar 

  • Burns, J. J., Salvador, R., Lemberger, L.: Metabolic blockade by methoxamine and its analogs. Ann. N. Y. Acad. Sci 139, 833 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Cannon, W. B., Rosenblueth, A.: Automatic neuroeffector systems. New York: Macmillan 1937.

    Google Scholar 

  • Conolly, M. E., Kersting, F., Dollery, C. T.: The clinical pharmacology of beta-adrenoceptor blocking drugs. Progr. cardiovasc. Dis. 19, 203 (1976).

    CAS  Google Scholar 

  • Conway, F. J., Fitzgerald, J. D., Mcainsh, J., Rowlands, D. J., Simpson, W. T.: Human pharmacokinetic and pharmacodynamic studies on atenolol (ICI 66, 082), a new cardioselective ß-adrenoceptor blocking drug. Brit. J. clin. Pharmacol. 3, 267 (1976).

    CAS  Google Scholar 

  • Dale, H. H.: On some physiological actions of ergot. J. Physiol. (Lond.) 34, 163 (1906).

    Google Scholar 

  • Davidson, C., Thadani, U., Goldstraw, P., Watt, S. J., Thomas, R. D., Taylor, S. H., Hess, H., Riess, W.: Studies with slow-release oxprenolol. I. Acute administration to normal man. In: Topics in cardiovascular disease (L. Judd, Hrsg.) S. 75. Horsham: Ciba 1977.

    Google Scholar 

  • Day, J. L.: The metabolic consequences of adrenergic blockade: A review. Metabolism 24, 987 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Dollery, C. T., Paterson, J. W., Conolly, M. E.: Clinical pharmacology of beta-receptor-blocking drugs. Clin. Pharmacol. Ther. 10, 765 (1969).

    CAS  Google Scholar 

  • Editorial: Hazards of non-practolol beta-blockers. Brit. med. J. 1977 I, 529.

    Google Scholar 

  • Ehrlich, P.: Ansprache bei der Einweihung des Georg-SpeyerHauses. In: The collected papers of Paul Ehrlich, Bd. 3 ( F. Himmelweit, Hrsg). London: Pergamon 1960.

    Google Scholar 

  • Fitzgerald, J. D.: Perspectives in adrenergic beta-receptor blockade. Clin. Pharmacol. Ther. 10, 292 (1969).

    PubMed  CAS  Google Scholar 

  • Formgren, H.: The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics. Brit. J. Clin. Pharmacol. 3, 1007 (1976).

    CAS  Google Scholar 

  • Gibson, D. G.: Pharmacodynamic properties of ß-adrenergic receptor blocking drugs in man Drugs 7, 8 (1974).

    CAS  Google Scholar 

  • Goodman, L. S., Gilman, A.: The pharmacological basis of therapeutics. New York: Macmillan 1975.

    Google Scholar 

  • Greenblatt, D. J., Koch-Weser, J.: Adverse reactions to propranolol in hospitalized medical patients: Report from the Boston Collaborative Drug Surveillance Program. Amer. Heart J. 86, 478 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann, B. F., Singer, D. H.: Appraisal of the effects of catecholamines on cardiac electrical activity. Ann. N.Y. Acad. Sci. 139, 914 (1967).

    Article  Google Scholar 

  • Joxxsson, G., Regqrdh, C.-G.: Clinical pharmacokinetics of ßadrenoreceptor blocking drugs. Clin. Pharmacokin. 1, 233 (1976).

    Article  Google Scholar 

  • Kendall, M.: Slow-Trasicor volunteer study: Blood levels and beta-blocking effect. In: Tropics in cardiovascular disease (L. Judd, Hrsg.), S. 87 Horsham: Ciba 1977.

    Google Scholar 

  • Koelle, G. B.: Neurohumoral transmission and the autonomic nervous system. In: The pharmacological basis of therapeutics (L. S. Goodman, A. Gilman, Hrsg.), 5. Aufl., S. 404 New York: Macmillan 1975.

    Google Scholar 

  • Krawietz, W., Poppert, D., Erdmann, E., Glossmann, H., Struck, C. J., Konrad, C.: ß-adrenergic receptors in guinea-pig myocardial tissue. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 295, 215 (1976).

    CAS  Google Scholar 

  • Lands, A. M., Arnold, A., Mcauliff, J. P., Luduena, F. P., Brown, J. G.: Differentiation of receptor systems activated by sympathomimetic amines Nature 214, 597 (1967).

    CAS  Google Scholar 

  • Langley, J. N.: On the reaction of cells and of nerve endings to certain poisons chiefly as regards the reaction of striated muscle to nicotine and to curare. J. Physiol. (Lond.) 33, 374 (1905).

    Google Scholar 

  • Lefkowitz, R. J.: Isolated beta-adrenergic binding sites: A potential assay vehicle for catecholamines. Pharmacol. Rev. 25, 259 (1973).

    PubMed  CAS  Google Scholar 

  • Levy, B., Ahlquist, R. P.: Adrenergic receptors in intestinal smooth muscle. Ann. N. Y. Acad. Sci 139, 781 (1967).

    Article  CAS  Google Scholar 

  • Lochner, W., Müller-Ruchholtz, E. R., Lösch, H.-M., Grund, E.: Kreislaufwirkungen einer ß-Blockade bzw.)6- adrenergen Stimulation unter besonderer Berücksichtigung des kapazitiv-venösen Systems des großen Kreislaufs. In: Beta-Blockade 1977 (W. Maurer, A. Schöming, R. Dietz, P. R. Lichtlen, Hrsg.), S. 148. Stuttgart: Thieme 1978.

    Google Scholar 

  • Lundborg, P., Steen, B.: Plasma levels and effect on heart rate and blood pressure of metoprolol after acute oral administration in 12 geriatric patients. Acta med. scand. 200, 397 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Lydtin, H.: Die medikamentöse Blockade der adrenergen ß-Receptoren. Dtsch. med. Wschr. 92, 401 (1967).

    CAS  Google Scholar 

  • Lyarix, H.: ß-Rezeptorenblocker. Ergebn. inn. Med. Kinderheilk. 30, 96 (1970).

    Google Scholar 

  • Lydtin, H.: Die Wirkung der Betarezeptorenblocker auf die Dynamik des gesunden und ischämischen Herzens. In: Koronarinsuffizienz (Holtmeier, Siegenthaler, Hrsg.), S. 51. Stuttgart: Thieme 1975.

    Google Scholar 

  • Lydtin, H.: Side effects and contraindication of beta-receptor blocking agents. Klin. Wschr. 55, 485 (1977).

    Article  Google Scholar 

  • Lydtin, H., Lohmöller, G.: Betareceptorenblocker. Lugano — München: Aesopus 1977.

    Google Scholar 

  • Lydtin, H., Lohmöller, G, Daniel, W., Schierl, W., Schewe, S., Kempter, H., Lohmöller, R, Walter, I., Kusus, T.: Kardiovasculäre Wirkungen von Glucagon vor und nach Propranololgabe. Verh. dtsch. Ges. inn. Med. 77, 1000 (1971).

    PubMed  CAS  Google Scholar 

  • Mason, W. D., Winer, N.: Pharmacokinetics of oxprenolol in normal subjects. Clin. Pharmacol. Ther. 20, 401 (1976).

    PubMed  CAS  Google Scholar 

  • Maxwell, D. R., Collins, R. F.: Acetbutolol — Review of the pharmacology and pharmacokinetics. Clin. Trials J. 2, (Suppl. 3) 9 (1974).

    Google Scholar 

  • Meier, J., Lydtin, H., Zöllner, N.: über die Wirkung von adrenergen ß-Rezeptorenblockern auf ventilatorische Funktionen bei obstruktiven Lungenkrankheiten. Dtsch. med. Wschr. 91, 145 (1966).

    CAS  Google Scholar 

  • Moran, N. C., Perkins, M. E.: Adrenergic blockade of the mammalian heart by a dichloroanalogue of isoproterenol. J. Pharmacol. exp. Ther. 124, 223 (1958).

    PubMed  CAS  Google Scholar 

  • Nicholls, J. F.: Practolol induced oculomucocutaneous syndrome. In: Beta-adrenerge Blocker und Hochdruck (D. Ganten, R. Dietz, B. Lüth, F. Gross Hrsg.) S. 178. Stuttgart: Thieme 1976.

    Google Scholar 

  • Nickerson, M., Collier, B.: Drugs inhibiting adrenergic nerves and structures innervated by them. In: The pharmacological basis of therapeutics (L. S. Goodman, A. Gilman, Hrsg.), 5. Aufl., S. 533. New York: Macmillan 1975.

    Google Scholar 

  • Nies, A. S., Shand, D. G.: Clinical pharmacology of propranolol. Circulation 52, 6 (1975).

    PubMed  CAS  Google Scholar 

  • Noordhoek, J.: Pharmacokinetics of beta-adrenoceptor blocking agents. In: Beta-adrenoceptor blocking agents (P. R. Saxena, R. P. Forsyth, Hrsg.), S. 79. Amsterdam: North Holland 1976.

    Google Scholar 

  • Ohnhaus, E. E., Nüesch, E., Meier, J., Kalberer, F.: Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia. Europ. J. clin. Pharmacol. 7, 25 (1974).

    Article  CAS  Google Scholar 

  • Om, S., Levy, G.: Relationship between renal function and elimination kinetics of pindolol in man. Europ. J. clin. Pharmacol. 9, 115 (1975).

    Article  Google Scholar 

  • Paget, G. E.: Carcinogenic action of pronethalol. Brit. med. J. 1963 II, 603.

    Google Scholar 

  • Petrie, J. C., Galloway, D. B., Jeffers, T. A., Webster, J.: Adverse reactions to beta-blocking drugs: A review. Postgrad. med. J. 52, (Suppl. 4) 63 (1976).

    Google Scholar 

  • Pitone, J. M., Lowenthal, D. T., Onesti, G., Afrime, M. B., Nancarow, J. F., Swartz, C.: Timolol maleate (TM) pharmacokinetics in chronic renal disease (CRD). Clin. Pharmacol. Ther. 21, 114 (1977).

    Google Scholar 

  • Powell, C. E., Slater, I. H.: Blocking of inhibitory adrenergic receptors by a dichloranalogue of isoproterenol. J. Pharmacol. exp. Ther. 122, 480 (1958).

    PubMed  CAS  Google Scholar 

  • Prichard, B. N. C., Gillam, P. M. S.: Use of propranolol (Inderal) in treatment of hypertension. Brit. med. J. 1964 II, 725.

    Article  Google Scholar 

  • Robison, G. A., Butcher, R. W., Sutherland, E. W.: Adenyl cyclase as an adrenergic receptor. Ann. N. Y. Acad. Sci. 139, 703 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Roskamm, H.: Hämodynamik und Kontraktilität in Ruhe und während körperlicher Belastung bei ß-Sympathikolyse. In: Dengler, H. J.: Die therapeutische Anwendung ß-sympathikolytischer Stoffe. S. 160. Stuttgart, New York: Schattauer 1972.

    Google Scholar 

  • Roskamm, H., Skinner, J., Lesch, A., Wink, K., Schnellbacher, K., Schwendel, V., Reindell, H.: Die Kontraktilitätsreserve des gesunden linken Ventrikels bei körperlicher Belastung nach ß-Rezeptorenblockade. Z. Kreislaufforsch. 61, 802 (1972).

    PubMed  CAS  Google Scholar 

  • Sawchuk, D. G., Robayo, J., Miller, K. W.: The distribution of Propanolol between blood and plasma in hypertensive patients. Brit. J. clin. Pharmacol. 1, 440 (1974).

    Google Scholar 

  • Schröder, G., Werkö, L.: Nathalide, a ß-adrenergic blocking agent. Clin. Pharmacol. Ther. 5, 159 (1964).

    Google Scholar 

  • Shand, D. G.: Pharmacokinetic properties of the ß-adrenergic receptor blocking drugs. Drugs 7, 39 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Sowrox, E., DAS Gupta, D. S., Baker, I.: Comparative effects of beta adrenergic blocking drugs. Thorax 30, 9 (1975).

    Article  Google Scholar 

  • Starke, K., Endo, T., Borowski, E., Taube, H. D.: Regelung der peripheren und zentralen noradrenergen Erregungsübertragung. In: Beta-adrenerge Blocker und Hochdruck (D. Ganten, R. Dietz, B. Luth, F. Gross, Hrsg.), S. 18. Stuttgart: Thieme 1976.

    Google Scholar 

  • Stephen, S. A.: Unwanted effects of propranolol. Amer. J. Cardiol. 18, 463 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Sundquist, H.: Pharmacokinetics and hypotensive effect of the beta-blocker sotalol. Acad. diss. Jaakkoo-Taara Oy-Turku 1976.

    Google Scholar 

  • Sutherland, E. W., Robison, G. A., Butcher, R. W.: Some aspects of the biological role of adenosine 3,5monophosphate (cyclic AMP). Circulation 37, 279 (1968).

    CAS  Google Scholar 

  • Thiringer, G., Svedmyr, N.: Interaction of orally administered metoprolol, practolol and propranolol with Isoprenaline in asthmatics. Europ. J. clin. Pharmacol. 10, 163 (1976).

    Article  Google Scholar 

  • Thompson, F. D., Joekes, A. M., Foulkes, D. M.: Pharmacodynamics of propranolol in renal failure. Brit. med. J. 1972 II, 434.

    Article  Google Scholar 

  • Wright, P.: Untoward effects associated with practolol administration: Oculomucocutaneous syndrome. Brit. med. J. 1975 1, 595.

    CAS  Google Scholar 

  • Zech, P., Sassard, N., Pozet, N., Legheand, D. J.: The pharmacokinetics of Tenormin in patients suffering from renal insufficiency (abstract 89 ). Tenth Annual Meeting of the European Society for Clinical Investigation, Rotterdam 1976.

    Google Scholar 

  • Zöllner, N., Lohmöller, G, Schnelle, K., Lydtin, H.: The effects of cardiac glycosides and of a ß-receptor blocking agent on the u. 1. f. displacement ballistocardiogram in healthy young men. Bibl. cardiol. (Basel) 26, 42 (1970).

    Google Scholar 

Download references

Authors
  1. H. Lydtin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Lohmöller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lydtin, H., Lohmöller, G. (1982). β-Receptorenblocker. In: Herzkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96617-0_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96617-0_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-96618-7

  • Online ISBN: 978-3-642-96617-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation